Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis

Scandinavian Journal of Immunology

Volumn 45, Issue 2, 1997, Pages 115-131

  Andersen, P ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

HOST RESISTANCE; HUMAN; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; T LYMPHOCYTE; TUBERCULOSIS;

EID: 0031034737     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-380.x     Document Type: Review

References (222)

1. Memorandum from a WHO meeting. Tuberculosis control and research strategies for the 1990s. Bulletin of the WHO 1992;70: 17-21.
2. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-64.
3. Smith DW. Protective effect of BCG in experimental tuberculosis. Adv Tuberc Res 1985;22:1-97.
4. Fine PE. The BCG story: lessons from the past and implications for the future. Rev Infect Diseases 1989;11:353-8.
5. ICMR/WHO Scientific Group. Vaccination against tuberculosis. WHO Technical Report Series 651, 1980.
6. ten Dam HG. Research on BCG vaccination. Adv Tuberc Res 1984;21:79-106.
7. Memorandum from a WHO meeting. Plan of action for research in the immunology of tuberculosis. Bulletin of the WHO 1983;61: 779-85.
8. WHO. WHO attacks global neglect of tuberculosis crisis. Millions dying from 'low priority' disease. Press Release, 1993.
9. Mackaness GB. The relationship of delayed hypersensitivity to acquired cellular resistance. Br Med Bull 1967;23:52-4.
10. Collins FM. Protection against mycobacterial disease by means of live vaccines tested in experimental animals. In: Kubica GP, Wayne LG eds. The Mycobacteria, a Source Book. New York: Marcel Dekker, 1984:787-40.
11. Orme IM. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988;56:3310-12.
12. Wiegeshaus E, Balasubramanian V, Smith DW. Immunity to tuberculosis from the perspective of pathogenesis. Infect Immun 1989;57:3671-6.
13. Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993;150:2920-30.
14. Riley LW. Determinants of cell entry and intracellular survival of Mycobacterium tuberculosis. Trends in Microbiol 1995;375:155-8.
15. Davatelis G, Tekamp-Olson P, Wolpe SD et al. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med 1988;167:1939-44.
16. + T cells in response to MIP-1α and MIP-1β. Science 1993;260:355-9.
17. Taub DD, Lloyd AR, Conlon K et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993;177:1809-14.
18. Murphy WJ, Tian Z-G, Asai O et al. Chemokines and T lymphocyte activation. II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J Immunol 1996;156:2104-11.
19. Dannenberg AM. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991;12:228-33.
20. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987;138:293-8.
21. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991;59:1558-63.
22. Andersen P, Askgaard D, Gottschau A et al. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol 1992;36:823-31.
23. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-25.
24. Andersen P, Andersen ÅB, Sørensen AL, Nagai S. Recall of longlived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995;154:3359-72.
25. Turk JL, Narayanan RB. The origin, morphology and function of epithelioid cells. Immunobiol 1982;161:274-82.
26. Kindler V, Sappino A-P, Grau GE, Piguet P-F, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-40.
27. Smith DW, Wiegeshaus EH. What animal models can teach us about the pathogenesis of tuberculosis in humans. Rev Infect Dis 1989;11:385-93.
28. Lurie MB, Zappasodi P. Studies on the mechanism of immunity in tuberculosis. The fate of tubercle bacilli ingested by mononuclear phagocytes derived from normal and immunized animals. J Exp Med 1942;75:247-67.
29. Raffel S. Types of acquired immunity against infectious disease. Ann Rev Microbiol 1949;3:221-64.
30. Chase MW. The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc Soc Exp Biol Med 1945;59:134-46.
31. Suter E. Passive transfer of acquired resistance to infection with Mycobacterium tuberculosis by means of cells. Am Rev Respir Dis 1961;83:535-43.
32. Mackaness GB. Cellular resistance to infection. J Exp Med 1962;116:381-406.
33. Mackaness GB, Blanden RV. Cellular immunity. Prog Allergy 1967;11:89-140.
34. Mackaness GB. The immunology of antituberculosis immunity. Amer Rev Respir Dis 1968;97:337-44.
35. North RJ. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol 1973;7:166-76.
36. Lefford MJ. Transfer of adoptive immunity to tuberculosis in mice. Infect Immun 1975;11:1174-81.
37. Harding CV, Geuze HJ. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol 1992;119:531-42.
38. Buus S, Colon S, Smith C et al. Interaction between a 'processed' ovalbumin peptide and Ia molecules. Proc Natl Acad Sci USA 1986;83:3968-71.
39. + T lymphocytes in intracellular microbial infections. Immunol Today 1988;9:168-73.
40. Myrvik QN, Leake ES, Wright MJ. Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. Am Rev Respir Dis 1984;129: 322-8.
41. McDonough KA, Kress Y, Bloom BR. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 1993;61:2763-73.
42. Harding CV. Pathways of antigen processing. Curr Opin Immunol 1991;3:3-9.
43. Hart PD, Armstrong JA, Brown CA, Draper P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun 1972;5:803-7.
44. Rulong SR, Aguas AP, Da Silva PP, Cilva MT. Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: freeze fracture analysis of infected mouse liver. Infect Immun 1991;59:3895-902.
45. Xu S, Cooper A, Sturgill-Koszycki S et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium - infected macrophages. J Immunol 1994;153:2568-78.
46. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Diseases 1993;167:1481-97.
47. Denis M, Gregg EO, Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmac 1990;12:721-7.
48. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175: 1111-22.
49. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995;63:736-40.
50. Sturgill-Koszycki S, Schlesinger P, Chakraborty P et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994;263:678-81.
51. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-63.
52. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1987;136:2348-57.
53. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies. J Exp Med 1986;166:1229-44.
54. Reed SG, Scott P. T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 1993;5:524-31.
55. Nathan CF, Murray HW, Wiebe E, Rubin BY. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983;158:670-89.
56. Flesch I, Kaufmann SHE. Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol 1987;138:4408-13.
57. Flesch IEA, Kaufmann SHE. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun 1990;58:2675-7.
58. Flynn JL, Chan J, Triebold KJ et al. An essential role for interferon-γ in resistance to M. tuberculosis infection. J Exp Med 1993;178:2249-54.
59. Cooper AM, Dalton DK, Stewart TA et al. Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J Exp Med 1993;178:2243-8.
60. Rook GAW. The role of activated macrophages in protection and immunopathology in tuberculosis. Res Microbiol 1990;141:253-6.
61. Haak-Frendscho M, Brown JF, Iizawa Y, Wagner RD, Czuprynski CJ. Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol 1992;148:3978-85.
62. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992;148:1792-6.
63. Appelberg R, Orme IM, de Sousa MIP, Silva MT. In vitro effects of interleukin-4 on interferon-γ-induced macrophage activation. Immunology 1992;76:553-9.
64. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46: 111-47.
65. + thymocytes selected by MHC class I molecules. Science 1994;263:1774-8.
66. intermediate liver lymphocytes are down-regulated by Listeria monocytogenes. Eur J Immunol 1995;25: 3321-5.
67. Swain SL, Huston G, Tonkonogy S, Weinberg A. Transforming growth factor β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991;147: 2991-3000.
68. Hirsh CS, Hussain R, Toossi Z, Dawood G, Shadid F, Elner JJ. Cross modulation by transforming growth factor β in human tuberculosis: suppresion of antigen-driven blastogenesis and interferon γ production. Proc Natl Acad Sci USA 1996;93:3193-8.
69. Haanen JBAG, de Waal Malefijt R, Res PCM et al. Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 1991;174:583-92.
70. Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991;254:279-82.
71. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.
72. Flynn JL, Goldstein MM, Triebold KJ et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155:2515-24.
73. Castro G, Silva RA, Appelberg R. Endogenously produced IL-12 is required for the induction of protective T-cells during Mycobacterium avium in infections in mice. J Immunol 1995;155: 2013-9.
74. Fulton SA, Johnsen JM, Wolf SF, Sieburth DS, Boom HW. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996;64:2523-31.
75. Flesch IEA, Hess JH, Huang S et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J Exp Med 1995;181:1615-21.
76. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-8.
77. Kaleab B, Ottenoff T, Converse P et al. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol 1990;20: 2651-9.
78. + T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur J Immunol 1993;23:2189-95.
79. Munk ME, de Bruyn J, Gras H, Kaufmann SHE. The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T-cell responses. Infect Immun 1994;62:726-8.
80. Flynn JL, Golstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-17.
81. Ladel CH, Daugelat S, Kaufmann SHE. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class-I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 1995;25:377-84.
82. Borst J, van de Griend RJ, van Oostveen JW et al. A T-cell receptor γ/CD3 complex found on cloned functional lymphocytes. Nature 1987;325:683-8.
83. Nakanishi N, Maeda K, Ito K, Heller M, Tonegawa S. Tγ protein is expressed on murine fetal thymocytes as a disulfide-linked heterodimer. Nature 1987;325:720-3.
84. Janis EM, Kaufmann SHE, Schwartz RH, Pardoll DM. Activation of γδ T cells in the primary immune response to Mycobacterium tuberculosis. Science 1989;244:713-6.
85. Born W, Hall L, Dallas A et al. Recognition of a peptide antigen by heat shock reactive γδ T lymphocytes. Science 1990;249:67-9.
86. + αβ T cell and γσ T cell responses to Mycobacterium tuberculosis. J Immunol 1995; 154:1786-96.
87. Pfeffer K, Schoel B, Gulle H, Kaufmann SHE, Wagner H. Primary responses of human T cells to mycobacteria: A frequent set of γ/δ T cells are stimulated by protease-resistant ligands. Eur J Immunol 1990;20:1175-9.
88. Constant P, Davodeau F, Peyrat M-A et al. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994; 264:267-71.
89. Schoel B, Sprenger S, Kaufmann SHE. Phosphate is essential for stimulation of Vγ9Vδ T lymphocytes by mycobacterial low molecular weight ligand. Eur J Immunol 1994;24:1886-92.
90. + T cells. Nature 1994;372:691-4.
91. Ladel CH, Blum C, Freher A, Reifenberg K, Kaufmann SHE. Protective role of γ/δ T cells and α/β T cells in tuberculosis. Eur J Immunol 1995;25:2877-81.
92. Nabeshima S, Hiromatsu K, Matsuzaki G et al. Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated γδ T-cell-depleted mice. Immunol 1995;84:317-21.
93. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell independent pathway of macrophage activation defined in the scid mouse. Immunol Rev 1991;124:5-24.
94. Molloy A, Meyn PA, Smith KD, Kaplan G. Recognition and destruction of bacillus calmette-guerin-infected human monocytes. J Exp Med 1993;177:1691-8.
95. Restrepo LM, Barrera LF, Garcia LF. Natural killer cell activity in patients with pulmonary tuberculosis and in healthy controls. Tubercle 1990;71:95-102.
96. + HLA-DR restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur J Immunol 1990;20:369-77.
97. Ota T, Okubo Y, Sekiguchi M. Analysis of immunologic mechanisms of high natural killer cell activity in tuberculosis pleural effusions. Am Rev Respir Dis 1990;142:29-33.
98. Lorgat F, Keraan MM, Lukey PT, Ress SR. Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculosis pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis 1992;145:418-23.
99. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993;178: 567-77.
100. North RJ, Deissler JF. Nature of 'memory' in T-cell-mediated antibacterial immunity: cellular parameters that distinguish between the active immune response and a state of 'memory'. Infect Immun 1975;12:761-7.
101. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988;140:3589-93.
102. hi 'Memory' phenotype display characteristics of activated cells in G1 stage of cell clyde. Cell Immunol 1992;141:433-43.
103. Michie CA, McLean A, Alcock C, Beverley PCL. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992;360:264-5.
104. Beverly PCL. Is T-cell memory maintained by crossreactive stimulation? Immunol Today 1990;11:203-5.
105. Lefford MJ, McGregor DD, Mackaness GB. Properties of lymphocytes which confer adoptive immunity to tuberculosis in rats. Immunology 1973;25:703-15.
106. Dianzani U, Luqman M, Rojo J et al. Molecular associations on the T cell surface correlate with immunological memory. Eur J Immunol 1990;20:2249-57.
107. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990;171:801-17.
108. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990;348:163-6.
109. Lightstone E, Marvel J, Mitchison A. Hyper-reactivity of mouse CD45RA-T cells. Eur J Immunol 1993;23:2383-6.
110. Sprent J. Immunological memory. The Immunologist 1995;3: 212-5.
111. Skamene E. Genetic control of resistance to mycobacterial infection. Curr Top Microbiol Immunol 1986;124:49-66.
112. Motulsky AG. Metabolic polymorphism and the role of infectious diseases in human evolution. Hum Biol 1960;32:28-62.
113. Comstock GW. Tuberculosis in twins: a re-analysis of the prophit survey. Am Rev Respir Dis 1978;117:621-5.
114. Gros P, Skamene E, Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 1981;127: 2417-21.
115. Schurr E, Buschman E, Malo D, Gros P, Skamene E. Immunogenetics of mycobacterial infections: mouse-human homologies. J Infect Dis 1990;161:634-9.
116. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for BCG. Cell 1993;73:469-85.
117. Vidal S, Tremblay ML, Govoni G et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the NRAMP 1 gene. J Exp Med 1995; 182:665-6.
118. Musa SA, Kim Y, Wang G, Dimmer C, Smith DW. Response of inbred mice to aerosol challenge with Mycobacterium tuberculosis. Infect Immun 1987;55:1862-6.
119. de Vries RRP. Regulation of T cell responsiveness against mycobacterial antigens by HLA class 2 immune response genes. Rev Infect Dis 1989;11:400-3.
120. Singh SPN, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983;148:676-81.
121. Bothamley GH, Beck JS, Schreuder GM et al. Association of tuberculosis and M. tuberculosis specific antibody levels with HLA. J Infect Dis 1989;159:549-55.
122. Closs O, Lovik M, Wigzell H, Taylor BA. H-2-linked gene(s) influence the granulomatous reaction to viable Mycobacterium lepraemurium in the mouse. Scand J Immunol 1983;18:59-63.
123. Huygen K, Palfliet K, Jurion F et al. H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (p32) of Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun 1988;65:3196-200.
124. Vordermeier HM, Harris DP, Friscia G et al. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur J Immunol 1992;22:2631-7.
125. Vordermeier HM, Harris DP, Moreno C, Ivanyi J. Promiscuous T cell recognition of an H-2 IA-presented mycobacterial epitope. Eur J Immunol 1994;24:2061-7.
126. Harris DP, Vordermeier HM, Friscia G et al. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cell. J Immunol 1993;150:5041-50.
127. Oftung F, Geluk A, Lundin KEA et al. Mapping of multiple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein. Infect Immun 1994;62:5411-8.
128. Koch R. Weitere mitteilung über das tuberkulin. Deutsche Medizinische Wochenschrift, 1891;43:1189-92.
129. Koch R. Über neue tuberkulinpräparate. Deutsche Medizinische Wochenschrift, 1897;14:209-13.
130. McNeil MR, Brennan PJ. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Res Microbiol 1991; 142:451-63.
131. Yuan Y, Lee RE, Besra GS, Belisle JT, Barry CE. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995;92:6630-4.
132. Brennan PJ. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis 1989;11:S420-30.
133. Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, Magnusson M. The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system. Scand J Immunol 1980;12:249-63.
134. Wiker HG, Harboe M, Bennedsen J, Closs O. The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with a reference system for Mycobacterium bovis, BCG. Scand J Immunol 1988;27:223-39.
135. Young DB, Kaufmann SHE, Hermans PWM, Thole JER. Mycobacterial antigens: a compilation. Mol Microbiol 1992;6:133-45.
136. Nagai S, Matsumoto J, Nagasuga T. Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG. Infect Immun 1981;31:1152-60.
137. Harboe M, Nagai S. MPB70 a unique antigen of Mycobacterium bovis BCG1-3. Am Rev Respir Dis 1984;129:444-53.
138. Abou-Zeid C, Smith I, Grange JM et al. The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol 1988;134:531-8.
139. Olivier D. Protein secretion in Escherichia coli. Ann Rev Microbiol 1985;39:615-48.
140. Bassford P, Beckwith J, Ito K et al. The primary pathway of protein export in E. coli. Cell 1991;65:367-8.
141. Wiker HG, Harboe M, Nagai S. A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis. J Gen Microbiol 1991;137:875-84.
142. Verbon A, Kuijper S, Jansen HM, Speelman P. Antigen in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J Gen Microbiol 1990;136: 955-64.
143. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991;59:1905-10.
144. Andersen ÅB, Andersen P, Ljungqvist L. Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun 1992;60:2317-23.
145. Sørensen AL, Nagai S, Houen G, Andersen P, Andersen ÅB. Purification and characterization of a low mass molecular mass T cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995;63:1710-7.
146. Zhang Y, Lathigra R, Garbe T, Catty D, Young D. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol Microbiol 1991;5:381-91.
147. Young DB, Garbe T, Lathigra R, Abou-Zeid C. Protein antigens: structure, function and regulation. In: McFadden JJ, Dale J eds. Molecular Biology of the Mycobacteria. Guildford: Surrey University Press, 1990:1-34.
148. Mackmann N, Nicaud JM, Gray L, Holland IB. Secretion of haemolysin by Escherichia coli. Curr Trop Microbiol Immunol 1986;125:159-81.
149. Wandersman C, Delepelaire P. To1C, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci USA 1990;87:4776-80.
150. Trias J, Jarlier V, Benz R. Porins in the cell wall of mycobacteria. Science 1992;258:1479-81.
151. Young DB, Garbe TR. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun 1991;59:3086-93.
152. Neidhardt FC, Van Bogelen RA. Heat shock response. In: Neidhardt FC, Ingraham JL, Low BK, Magasarik B, Schaechter M, Umbarger HE eds. Escherichia coli and Salmonella typhimurium. Cellular and Molecular Biology. Washington: ASM, 1988:1334-45.
153. Deshaies RJ, Koch BD, Werner-Washburne M, Craig EA, Schekman R. A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides. Nature 1988;332:800-5.
154. Mande SC, Mehra V, Bloom BR, Hol WGJ. Structure of the heat-shock protein chaperonin-10 of Mycobacterium leprae. Science 1996;271:203-07.
155. Rocchi G, Pavesi A, Ferrari C, Bolchi A, Manara GC. A new insight into the suggestion of a possible antigenic role of a member of the 70 kDa heat shock proteins. Cell Biol Int 1993;17: 83-91.
156. Romain F, Laqueyrerie A, Militzer P et al. Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immun 1993;61:742-50.
157. Romain F, Augier J, Pescher P, Marchal G. Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria. Proc Natl Acad Sci USA 1993;90:5322-6.
158. Laqueyrerie A, Militzer P, Romain F et al. Cloning, sequencing and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigens. Infect Immun 1995;63:4003-10.
159. Young DB, Garbe TR. Lipoprotein antigens of Mycobacterium tuberculosis. Res Microbiol 1991;142:55-65.
160. Andersen ÅB, Ljunqvist, L, Olsen M. Evidence that protein antigen b of Mycobacterium tuberculosis is involved in phosphate metabolism. J Gen Microbiol 1990;136:477-80.
161. Espitia C, Elinos M, Hernández-Pando R, Mancilla R. Phosphate starvation enhances expression of the immunodominant 38-kilodalton protein antigen of Mycobacterium tuberculosis: demonstration by immunogold electron microscopy. Infect Immun 1992; 60:2998-3001.
162. Andersen ÅB, Hansen EB. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun 1989;57: 2481-8.
163. Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992;56:648-61.
164. Abou-Zeid C, Garbe T, Lathigra R et al. Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun 1991;59:2712-8.
165. Belisle JT, Sievert T, Takayana K, Besra GS. Identification of a mycolyltransferase from Mycobacterium tuberculosis and the coincident definition of the physiological function of antigen 85B. In: Program of the 30th Joint Conference on Tuberculosis and Leprosy, US-Japan Cooperative Medical Science Program. NIAID. NIH. ft Collins Colo. 1995:212-6.
166. Wiker HG, Sletten K, Nagai S, Harboe M. Evidence of three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect Immun 1990;58:272-4.
167. Content J, de la Cuvellerie A, de Wit L et al. The genes coding for the antigen 85 complexes of Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 1991;59:3205-12.
168. Wiker HG, Nagai S, Harboe M, Ljungqvist L. A family of cross-reacting proteins secreted by M. tuberculosis. Scand J Immunol 1992;36:307-19.
169. Li H, Ulstrup JC, Jonassen TØ et al. Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect Immun 1993;61:1730-4.
170. Mahairas GG, Sabo PJ, Mickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996;178:1274-82.
171. Kusunose E, Ichihara K, Noda Y, Kusunose M. Superoxide dismutase from Mycobacterium tuberculosis. J Biochem 1976;80:1343-52.
172. Fifis T, Cosopoulos C, Radiford AJ, Bacic A, Wood PR. Purification and characterization of major antigens from a Mycobacterium bovis culture filtrate. Infect Immun 1991;59:80.
173. Garbe T, Harris D, Vordermeier M et al. Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun 1993;61:260-7.
174. Ashbridge KR, Booth JDW, Lathigra RB. Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis. Nucleoic Acids Res 1989;17:1249.
175. Verbon A, Hartskeerl RA, Schuitema A et al. The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the Alpha-Crystallin family of low-molecular-weight heat shock proteins. J Bacteriol 1992;174:1352-9.
176. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996;64:16-22.
177. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991;59:372-82.
178. Bermudez LE, Young LS, Martinelli J, Petrofsky M. Exposure to ethanol up-regulates the expression of Mycobacterium avium complex associated with bacterial virulence. J Infect Dis 1993; 168:961-8.
179. Alavi MR, Affronti LF. Induction of mycobacterial proteins during phagocytosis and heat shock: a time interval analysis. J Leukocyte Biol 1994;55:633-41.
180. Lee B, Horwitz HA. Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J Clin Invest 1995;96:245-9.
181. Plum G, Clark-Curtiss JE. Induction of Mycobacterium avium gene expression following phagocytes by human macrophages. Infect Immun 1994;62:476-83.
182. Lee B, Hefta SA, Brennan PJ. Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun 1992;60:2066-74.
183. Worsaae A, Ljungqvist L, Hasløv K, Heron I, Bennedsen J. Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun 1987;55:2922-7.
184. Kadival GV, Chaparas SD, Hussong D. Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis. J Immunol 1987;139:2447-51.
185. Shinnick TM, Vodkin MH, Williams JC. The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and the Escherichia coli GroEL protein. Infect Immun 1988;56:446-51.
186. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T cell responses to secreted antigen of Mycobacterium tuberculosis. Infect Immun 1995;63:1491-7.
187. Mehra V, Bloom BR, Torigian VK et al. Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. J Immunol 1989;15:2873-8.
188. Mehra V, Bloom BR, Bajardi AC et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 1992;175:275-84.
189. Barnes PF, Mehra V, Rivoire B et al. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol 1992;148: 1835-40.
190. Wallis RS, Paranjape R, Phillips M. Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect Immun 1993;61:627-32.
191. Towbin H, Staehlin T, Gordon J. Eleetrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets, procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
192. Young DB, Lamb JR. T lymphocytes respond to solid-phase antigen, a novel approach to the molecular analysis of cellular immunity. Immunology 1986;59:167-71.
193. Abou-Zeid C, Filley E, Steele J, Rook GAW. A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen bearing particles. J Immunol Methods 1987;98:5-10.
194. Andersen P, Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 1993;61:844-51.
195. Andersen P, Heron I. Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods 1993;161:29-39.
196. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994;62:2536-44.
197. Hasløv K, Andersen ÅB, Nagai S, Gottschau A, Sørensen T, Andersen P. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 1995;63: 804-10.
198. Gulle H, Schoel B, Kaufmann SHE. Direct blotting with viable cells of protein mixtures separated by two-dimensional gel electrophoresis. J Immunol Methods 1990;133:253-61.
199. Huygen K, Abramowitz D, Vandenbusche P. Spleen cell cytokine secretion in Mycobacterium bovis-BCG infected mice. Infect Immun 1992;60:2880-6.
200. Roberts AD, Sonnenberg MG, Ordway DJ et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunol 1995;85:502-8.
201. Griffin JP, Orme IM. Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun 1994;62:1683-90.
202. Orme IM, Miller ES, Roberts AD et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. J Immunol 1992;148:189-98.
203. Lefford MJ, McGregor DD. Immunological memory in tuberculosis. Influence of persisting viable organisms. Cell Immunol 1974;14:417-28.
204. + (memory) T cells. Eur J Immunol 1990;20:307-15.
205. Brandt L, Oettinger T, Holm A, Andersen P. Key epitopes on the secreted ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996;157:3527-33.
206. Weiss DW. Antituberculosis vaccination in the guinea pig with non-living vaccines. Am Rev Tuberc Pulm Dis 1958;77:719-24.
207. Wiegeshaus EH, McMurray DN, Graver AA, Harding GE, Smith DW. Host-parasite relationship in experimental airborne tuberculosis. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am Rev Respir Dis 1970;102:422-9.
208. Larson CL, Ribi E, Wicht WC, List RH, Goode G. Resistance to tuberculosis in mice immunized with BCG disrupted in oil. Nature 1963;198:1214-5.
209. Ribi E, Anacker RL, Brehmer W et al. Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines. J Bacteriol 1966;92:869-79.
210. Ribi E, Larson C, Wicht W, List R, Goode G. Effective nonliving vaccine against experimental tuberculosis in mice. J Bacteriol 1966;91:975-83.
211. Anacker RL, Barclay WR, Brehmer W, Larson CL, Ribi E. Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG. J Immunol 1967;98:1265-73.
212. Masihi KN, Brehmer W, Azuma I, Lange W, Müller S. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate. Infect Immun 1984;43:233-7.
213. Hubbard RD, Flory CM, Collins FM. Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 1992;87:94-8.
214. Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992;60:4781-92.
215. Horwitz MA, Lee B-WE, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci 1995;92:1530-4.
216. Weis DR, Dubos RJ. Antituberculosis immunization induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract. J Exp Med 1955;101:313-30.
217. Youmans GB. Relation between delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis 1975;111:109-18.
218. Løvik M, Closs O. Repeated delayed-type hypersensitivity reactions against Mycobacterium lepraemurium antigens at the infection site do not affect bacillary multiplication in C3H mice. Infect Immun 1982;36:768-74.
219. Tsukada H, Kawamura I, Arakawa M, Nomoto K, Mitsuyama M. Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect Immun 1991;59:3589-95.
220. +) in classical delayed-type (tuberculin) hypersensitivity reaction in human skin. J Immunol 1992;148:2058-61.
221. Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
222. Lyons J, Sinos C, Destree A, Caiazzo T, Havican K. Expression of Mycobacterium tuberculosis and Mycobacterium leprae proteins by vaccinia virus. Infect Immun 1990;58:4089-98.